January 30, 2005 -- For the first time so far this year, stocks managed to put together a positive showing during the last week. The Centient Biotech 200 gained 21.48 points, a rise of .65%, to close at 3341.68. So far this year, the CBT 200 is down 6.64%. Over the past 12 months, the index is 7.5% above the lows set during last August, and 11.3% off the highs of Spring 2004. We discuss Affymetrix and Imclone, both of which bounced higher after delivering good earnings reports, and ViaCell, an IPO that keeps rising. Meanwhile, traders wonder whether the rise in stock prices is an authentic reversal to the upside, or merely a small rally in a larger bear move...
